Journal of Current Hematology & Oncology Research

Cover and Contents

Full Issue

Articles

Original Article - Oncology

Effect of vitamin D on prognosis in patients with gastric cancer

Yasin Sezgin

İbrahim Aydın

Abdurrahman Bicer

Alper Can

https://doi.org/10.51271/JCHOR-0026

: 553 : 1028

Citation : Sezgin Y, Aydın İ, Biçer A, Can A. Effect of vitamin D on prognosis in patients with gastric cancer. J Curr Hematol Oncol Res. 2024;2(1):1-5.

Original Article - Hematology

Do mean platelet volume and platelet count vary on a daily or gender basis?

Ömer Candar

Ömer Ekinci

Ali Doğan

Senar Ebinç

https://doi.org/10.51271/JCHOR-0027

: 5870 : 5369

Citation : Candar Ö, Ekinci Ö, Doğan A, Ebinç S. Do mean platelet volume and platelet count vary on a daily or gender basis? J Curr Hematol Oncol Res. 2024;2(1):6-9.

Original Article - Hematology

Factors affecting prognosis in myelodysplastic syndrome: an 11 years’ experience from a tertiary care center

Emrullah Doğan

Ekrem Küçükoğlu

Muzaffer Keklik

https://doi.org/10.51271/JCHOR-0028

: 2003 : 2613

Citation : Doğan E, Küçükoğlu E, Keklik M. Factors affecting prognosis in myelodysplastic syndrome: an 11 years’ experience from a tertiary care center. J Curr Hematol Oncol Res. 2024;2(1):10-14.

Original Article - Oncology

Comparison of efficacy and tolerability of single agent and double agent chemotherapy regimens in first-line treatment of elderly patients with her-2 negative metastatic gastric cancer

Gürkan Güner

Muslih Ürün

https://doi.org/10.51271/JCHOR-0029

: 768 : 899

Citation : Güner G, Ürün M. Comparison of efficacy and tolerability of single agent and double agent chemotherapy regimens in first-line treatment of elderly patients with HER-2 negative metastatic gastric cancer. J Curr Hematol Oncol Res. 2024;2(1):15-19.

Case Report - Hematology

Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis

Serhat Çelik

Leylagül Kaynar

https://doi.org/10.51271/JCHOR-0030

: 1269 : 960

Citation : Çelik S, Kaynar L. Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis. J Curr Hematol Oncol Res. 2023; 1(1): 15-17.

Letter to the Editor - Hematology

Contributions of ELN2022 update and new genetic analysis tests in the risk assesment and treatment of acute myeloid leukaemia

Seda Yılmaz

Metin Bağcı

Abdulkadir Baştürk

https://doi.org/10.51271/JCHOR-0031

: 627 : 694

Citation : Yılmaz S, Bağcı M, Baştürk A. Contributions of ELN2022 update and new genetic analysis tests in the risk assesment and treatment of acute myeloid leukaemia. J Curr Hematol Oncol Res. 2024;2(1):22-23.